Since rating Viasat ( VSAT) a hold in January, the stock has gained 260.33%. This beat the S&P 500, which rose by 13.47%. On ...

Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

OANDA reports government yields are rising due to increased debt, inflation, and low investor confidence, driving volatility ...

Enterprises today are equipped with a vast array of tools and technologies. The opportunity lies in bringing these ...

Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the ...

The Bloomberg Commodity Index has broken above a two-year downtrend, signaling that the second leg of the 2020s bull ...

Hatem Dhiab says AI spending and tech dominance aren’t a bubble as megacap earnings and cash flow keep the rally grounded in ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Unfortunately the Progress Software Corporation (NASDAQ:PRGS) share price slid 38% over twelve months. That contrasts poorly with the market return of 14%. However, the longer term returns haven't ...

Copper Futures, Crude Oil WTI Futures, Natural Gas Futures, SPDR® Gold Shares. Read 's Market Analysis on Investing.com ...

Background Pulsed field ablation (PFA) has emerged as a promising non-thermal alternative to conventional atrial fibrillation ...

Background The epidemiology of sudden cardiac arrest (SCA) in the Mediterranean area remains unclear. The aim of this study ...